Pay in 4 interest-free payments of $5.24 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
None of this proves a GLP-1 medication causes people to quit, and one longer trial found no lasting difference in quit rates at 12 months
Including a variety of foods in your diet prevents dietary boredom and promotes adherence
A recent study in The New England Journal of Medicine, aimed to evaluate the safety and efficacy of Retatrutide (LY3437943) drug and found that it was effective in reducing a significant amount of body weight and produced weight loss at levels never seen before in a pair of phase 2 studies that together randomized more than 600 people with overweight or obesity, with or without type 2 diabetes
Epub 2025 Jan 29
Data from the SURMOUNT program show constipation rates climbing in a clear dose-response pattern (6% at 5 mg, 8% at 10 mg, 11% at 15 mg)
